Verified Nov 2026
Other
·

Durham, North Carolina
·
Since 2005
Talecris Biotherapeutics, Inc., headquartered in Durham, North Carolina, was founded in 2005 as a global biopharmaceutical company producing plasma-derived protein therapies for rare and chronic conditions. With 1,000–5,000 employees and estimated revenue of $100–250 million, the company specialized in immunology, pulmonology, neurology, and hemostasis treatments including Gamunex and Prolastin. Grifols acquired Talecris in June 2011.
Talecris Biotherapeutics, Inc. at a glance
Revenue
$100-250M
Est. band
Employees
1,000-5,000
Founded
2005
Headquarters
Durham, North Carolina
Industries
Automotive
Electric Vehicles
Overview
Talecris Biotherapeutics, Inc., headquartered in Durham, North Carolina, was founded in 2005 as a global biopharmaceutical company producing plasma-derived protein therapies for rare and chronic conditions. With 1,000–5,000 employees and estimated revenue of $100–250 million, the company specialized in immunology, pulmonology, neurology, and hemostasis treatments including Gamunex and Prolastin. Grifols acquired Talecris in June 2011.
At a glance
Attribute | Detail |
|---|---|
Founded | 2005 |
Headquarters | Durham, North Carolina |
Employees | 1,000-5,000 |
Revenue | $100-250M (estimated) |
What Talecris Biotherapeutics, Inc. makes
Talecris produced immunoglobulins, alpha-1 proteinase inhibitors, albumin products for blood volume replacement, and hyperimmune globulins for critical care.
Latest developments
2026-07-08 — John Hanson (linkedin.com)
2026-04-15 — Ballas has consulting arrangements with Novartis DSMB (National Institute of Allergy and Infectious Diseases) and has received research support from Talecris Biotherapeutics, VA Merit Review, and the National Institutes of Health – Challenges Faced with Small Molecular Modulators of Dehydrogenase Inhibitors (engineering-gdfsuez.com)
2025-12-31 — The Evolution of Talecris Plasma: A Journey Through Innovation and Acquisition - Oreate AI Blog (oreateai.com)
2025-04-01 — Blood Money: The Cerberus-Talecris Deal That Redefined Biopharma (substack.com)
Facilities
Talecris Biotherapeutics, Inc. is headquartered in Durham, North Carolina. Public sources also reference these locations:
Clayton, North Carolina — webwire.com
Company details
Grifols' acquisition of Talecris in 2011 expanded the buyer's position in the global plasma protein therapeutics market. Talecris Biotherapeutics, Inc. was founded in 2005, has an estimated 1,000-5,000 employees, and is headquartered in Durham, North Carolina.
Frequently asked questions
What does Talecris Biotherapeutics, Inc. do?
Talecris Biotherapeutics, Inc., headquartered in Durham, North Carolina, was founded in 2005 as a global biopharmaceutical company producing plasma-derived protein therapies for rare and chronic conditions. With 1,000–5,000 employees and estimated revenue of $100–250 million, the company specialized in immunology, pulmonology, neurology, and hemostasis treatments including Gamunex and Prolastin. Grifols acquired Talecris in June 2011.
Where is Talecris Biotherapeutics, Inc. headquartered?
Talecris Biotherapeutics, Inc. is headquartered in Durham, North Carolina (79 TW Alexander Dr, Durham, North Carolina, 27709).
When was Talecris Biotherapeutics, Inc. founded?
Talecris Biotherapeutics, Inc. was founded in 2005.
How big is Talecris Biotherapeutics, Inc.?
Talecris Biotherapeutics, Inc. has an estimated 1,000-5,000 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.